IRWD icon

Ironwood Pharmaceuticals
IRWD

Overview Fund Activity

162 hedge funds and large institutions have $2.5B invested in Ironwood Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 54 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
-1
Holders Change %
-0.61%
% of All Funds
4.04%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
25
Increased
55
Reduced
54
Closed
18
Calls
$2.28M
Puts
$2.94M
Net Calls
-$656K
Net Calls Change
-$1.71M

Top Buyers

1
BlackRock
BlackRock
New York
+$193M
2
BCM
Brown Capital Management
Maryland
+$86.9M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$31M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$22.8M
5
Capital World Investors
Capital World Investors
California
+$22.7M

Top Sellers

1
JHIU
Janus Henderson Investors US
Colorado
-$76.9M
2
GIM
Granahan Investment Management
Massachusetts
-$18M
3
CC
Carlson Capital
Texas
-$11.1M
4
RCMNY
Rubric Capital Management (New York)
New York
-$7.25M
5
BM
Bridger Management
New York
-$5.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
PAM
176
Princeton Alpha Management
New Jersey
– -$156K -12,185 Closed
JIC
177
Joel Isaacson & Co
New York
– -$105K -8,179 Closed
Northwestern Mutual Wealth Management
178
Northwestern Mutual Wealth Management
Wisconsin
– -$3K -202 Closed
CG
179
Cutler Group
California
– -$1K -119 Closed
4 5 6 7
8